Shots: The US FDA has put a partial clinical hold on Aprea’s clinical program that evaluates eprenetapopt + acalabrutinib or with venetoclax and rituximab in patients with lymphoid malignancies. The […]readmore
Tags : Clinical Trials
Shots: The company launches Sensor Cloud for managing sensor and digital health technology data during the clinical trial. Sensor Cloud integrates with Medidata Rave Clinical Cloud and supports continuous patient […]readmore
Shots: Sanofi will sponsor the clinical trials while MSD will provide KEYTRUDA. Additionally, Sanofi is separately evaluating the activity of THOR-707 in combination with other anti-PD-1 antibodies, including Libtayo (cemiplimab-rwlc) […]readmore
With the race to develop an effective vaccine becoming intense, how has the coronavirus pandemic changed the pharmaceutical industry, and what can we expect in the long- and short-term? Let’s […]readmore
Shots: Zydus’ ZyCoV-D has completed the preclinical studies and has received DCGI approval to initiate P-I/II human clinical trials in India. In its preclinical study, the vaccine demonstrated that it […]readmore
Shots: Bharat Biotech has received DCGI approval to conduct P-I & II clinical studies assessing Covaxin, developed in collaboration with ICMR and NIV. The company anticipate initiating the clinical studies […]readmore
2020 is a year that nobody ever thought could turn their lives upside down. The beginning of this year witnessed the worldwide onset of Coronavirus disease or COVID-19 that has […]readmore
The Webinar on “Strategies to Conduct Clinical Trials effectively in Covid-19 era” organized by CliniMed LifeSciences Pvt. Ltd., Kolkata in association with Indian Society for Clinical Research (ISCR) and Peerless […]readmore
Claimed LifeSciences Pvt. Ltd., Kolkata is gladly organizing a Webinar on “Strategies to Conduct Clinical Trials effectively in Covid-19 era” in association with Indian Society for Clinical Research (ISCR) and […]readmore
Shots: The companies plan to file IND submission and initiate human clinical studies to evaluate neutralizing mAbs against COVID-19 in the US and China in Q2’2020 The article is being […]readmore